View of PD-1/PD-L1 Antibody versus Gefitinib for Advanced Non-small Cell Lung Cancer: A Systematic Review and Network Meta-analysis of Randomized Control Trials

Return to Article Details PD-1/PD-L1 Antibody versus Gefitinib for Advanced Non-small Cell Lung Cancer: A Systematic Review and Network Meta-analysis of Randomized Control Trials Download Download PDF